A principal active antimicrobial compound, 2-(3’,5'-dibromo-2'-methoxyphenoxy)-3,5-dibromophenol, was isolated from the methanol extract of Phyllospongia papyracea via bioassay-guided fractionation and isolation. The crude extract and the purified compound were assayed to determine the minimal inhibitory concentration and minimal bactericidal concentration (MBC) using the broth microdilution method. The purified compound was found to be highly active against Bacillus subtilis and Staphylococcus aureus at MIC=1 μg/mL, Campylobacter jejuni at MIC=2 μg/mL, Pseudomonas aeruginosa at MIC=4 μg/mL, and Streptococcus pneumoniae and Listeria monocytogenes at MIC = 8 μg/mL. The activity of this compound was found to be comparable with antibiotics commonly used to control these species of bacteria. The results establish 2-(3’,5'-dibromo-2'-methoxyphenoxy)-3,5-dibromophenol as a potential lead molecule for the development of antibacterial agents.
LooVG, PoirierL, MillerMA, OughtonM, LibmanMD, MichaudS, BourgaultA-M, NguyenT, FrenetteC, KellyM, VibienA, BrassardP, FennS, DewarK, HudsonTJ, HornR, RenéP, MonczakY, DascalA. (2005) A predominantly clonal multi-Institutional outbreak of Clostridium difficile–associated diarrhea with high morbidity and mortality. New England Journal of Medicine, 353, 2442–2449.
2.
ShridharDM, MahajanG, KamatV, NaikC, ParabR, ThakurN, MishraP. (2009) Antibacterial activity of 2-(2’,4'-dibromophenoxy)-4,6-dibromophenol from Dysidea granulosa. Marine Drugs, 7, 464–471.
3.
McDermottPF, Bodeis-JonesSM, FritscheTR, JonesRN, WalkerRD, SusceptibilityC. (2005) Broth microdilution susceptibility testing of Campylobacter jejuni and the determination of quality control ranges for fourteen antimicrobial agents. Journal of Clinical Microbiology, 43, 6136–6138.
4.
CraggGM, NewmanDJ, SnaderKM. (1997) Natural products in drug discovery and development. Journal of Natural Products, 60, 52–60.
5.
KelmanD, KashmanY, HillRT, RosenbergE and LoyaY. (2009) Chemical warfare in the sea: The search for antibiotics from Red Sea corals and sponges. Pure and Applied Chemistry, 81, 1113–1121.
6.
MayerAMS, RodríguezAD, BerlinckRGS, HamannMT. (2009) Marine pharmacology in 2005–6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochimica et Biophysica Acta (BBA) - General Subjects, 1790, 283–308.
7.
TiwariBK, ValdramidisVP, O’ DonnellCP, MuthukumarappanK, BourkeP, CullenPJ. (2009) Application of natural antimicrobials for food preservation. Journal of Agricultural and Food Chemistry, 57, 5987–6000.
8.
LiHJ, AmagataT, TenneyK, CrewsP. (2007) Additional scalarane sesterterpenes from the sponge Phyllospongia papyracea. Journal of Natural Products, 70, 802–807.
9.
PopovA, StekhovaS, UtkinaN, RebachukN. (1999) Antimicrobial and cytotoxic activity of sesquiterpenequinones and brominated diphenyl esters isolated from marine sponges. Pharmaceutical Chemistry Journal, 33, 71–73.
HattoriT, KonnoA, AdachiK and ShizuriY. (2001) Four new bioactive bromophenols from the palauan sponge Phyllospongia dendyi. Fisheries Science, 67, 899–903.
12.
ChenDK, McGeerA, de AzavedoJC, LowDE. (1999) Decreased Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. New England Journal of Medicine, 341, 233–239.
13.
HoPL, YungRWH, TsangDNC, QueTL, HoM, SetoWH, NgTK, YamWC, NgWWS. (2001) Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. Journal of Antimicrobial Chemotherapy, 48, 659–665.
14.
ArvandM, MoserV, SchwehnC, Bettge-WellerG, HensgensMP and KuijperEJ. (2012) High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. Plos One, 7, e30183.
15.
YoungKT, DavisLM and DiRitaVJ. (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nature Reviews Microbiology, 5, 665–679.
16.
LuangtongkumT, ShenZ, SengVW, SahinO, JeonB, LiuP and ZhangQ. (2012) Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in Its natural host. Antimicrobial Agents and Chemotherapy, 56, 1300–1308.
17.
National Committee for Clinical Laboratory Standards (United States). (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Clinical and Laboratory Standards Institute.
